Dyne Therapeutics, Inc. DYN Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $392.78M-1.4% | $398.33M+3.5% | $384.71M+1.2% | $380.29M+10.8% | $343.32M+22.0% | ||
| $78.31M+12.1% | $69.85M+8.4% | $64.46M+6.3% | $60.64M+12.7% | $53.79M-13.9% | ||
| $471.09M+0.6% | $468.18M+4.2% | $449.16M+1.9% | $440.93M+11.0% | $397.1M+15.5% | ||
| $471.09M+0.6% | $468.18M+4.2% | $449.16M+1.9% | $440.93M+11.0% | $397.1M+15.5% | ||
| -$471.09M-0.6% | -$468.18M-4.2% | -$449.16M-1.9% | -$440.84M-11.0% | -$397.01M-15.5% | ||
| $10.39M+67.9% | $6.19M+107% | $3M+3,089% | $94K— | $0— | ||
| $31.52M+5.5% | $29.86M+0.2% | $29.79M-2.6% | $30.59M-1.4% | $31.02M+15.2% | ||
| $19.38M-11.8% | $21.97M-13.4% | $25.36M-9.6% | $28.05M-6.4% | $29.97M+13.2% | ||
| -$451.71M-1.2% | -$446.21M-5.3% | -$423.8M-2.6% | -$412.89M-12.5% | -$367.13M-15.7% | ||
| -$3.19+9.1% | -$3.51+4.1% | -$3.66+5.2% | -$3.86-7.5% | -$3.59-7.2% | ||
| -$3.19+9.1% | -$3.51+4.1% | -$3.66+5.2% | -$3.86-7.5% | -$3.59-7.2% | ||
| -$452.09M-1.4% | -$445.75M-5.2% | -$423.78M-2.8% | -$412.39M-12.4% | -$366.76M-15.5% | ||
| $31.52M+5.5% | $29.86M+0.2% | $29.79M-2.6% | $30.59M-1.4% | $31.02M+15.2% | ||
| -$357K-173% | $490K— | —— | —— | —— | ||
| $19.38M-11.8% | $21.97M-13.4% | $25.36M-9.6% | $28.05M-6.4% | $29.97M+13.2% | ||
| -$1.74M-2.6% | -$1.7M-18.4% | -$1.43M+41.6% | -$2.45M-134% | -$1.05M-131% | ||
| 549.2M+11.2% | 494M+7.5% | 459.7M+9.8% | 418.8M+5.4% | 397.4M+7.8% | ||
| 549.2M+11.2% | 494M+7.5% | 459.7M+9.8% | 418.8M+5.4% | 397.4M+7.8% | ||
| -$471.09M-0.6% | -$468.18M-4.2% | -$449.16M-1.9% | -$440.84M-11.0% | -$397.01M-15.5% | ||
| -$469.02M-0.6% | -$466.16M-4.2% | -$447.21M-1.9% | -$438.99M-11.1% | -$395.26M-15.5% | ||
| -$469.02M-0.6% | -$466.16M-4.2% | -$447.21M-1.9% | -$438.99M-11.1% | -$395.26M-15.5% | ||
| -$471.09M-0.6% | -$468.18M-4.2% | -$449.16M-1.9% | -$440.84M-11.0% | -$397.01M-15.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Dyne Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Dyne Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.